NTF3 and sarcopenia: In this study, we provide strong evidence for the efficacy of AAV1.NT-3 gene therapy in sarcopenia and age related hypomyelination of peripheral nerves, as well as the maintenance of NMJ connectivity in 2-year-old C57BL/6 mouse, a model for natural aging.